Abstract Characterization of the genetic landscape of Alzheimer’s disease (AD) and related
dementias (ADD) provides a unique opportunity for a better understanding of the associated …

We describe a recently recognized disease entity, limbic-predominant age-related TDP-43
encephalopathy (LATE). LATE neuropathological change (LATE-NC) is defined by a …

Alzheimer's disease (AD) is a complex genetic disorder with no effective treatments. More
than 20 common markers have been identified, which are associated with AD. Recently, …

Results Serum levels of sclerostin and iPTH correlated negatively. In unadjusted analyses,
sclerostin correlated negatively with histomorphometric parameters of turnover, osteoblastic …

Genome-wide association studies are identifying novel Alzheimer's disease (AD) risk factors.
Elucidating the mechanism underlying these polymorphisms is critical to the validation …

Introduction The relationship of diabetes to specific neuropathologic causes of dementia is
incompletely understood. Methods We used logistic regression to evaluate the association …

Importance Compared with non-Hispanic White individuals, African American individuals
from the same community are approximately twice as likely to develop Alzheimer disease. …

Objective: We assessed salience of subjective memory complaints (SMCs) by older individuals
as a predictor of subsequent cognitive impairment while accounting for risk factors and …

Hippocampal sclerosis of aging (HS-Aging) is a causative factor in a large proportion of elderly
dementia cases. The current definition of HS-Aging rests on pathologic criteria: neuronal …

Human apolipoprotein E (apoE) isoforms may differentially modulate amyloid-β (Aβ) levels.
Evidence suggests physical interactions between apoE and Aβ are partially responsible for …